Marc Beer has recently moved up the ranks in his position at LumeNXT Inc. He was recently named Chairman of the Board. This is a huge step in his career. LumeNXT is a company that is privately owned and focuses their work mainly on the development of surgical products that help with minimally invasive surgeries. Marc Beer has a lot of experience working with things like this so he is very good at his job.
Follow Marc Beer Facebook
Marc Beer loves working with a company that is so dedicated to what they do. He knows that the job of LumeNXT will continue to increase in value as more and more surgeries become available for being minimally invasive. Marc Beer along with some of the highest up surgeons know that technology is what helps drive minimally invasive surgeries. Without technology, surgeons would have trouble with visualization, precision, and many other things.
LumeNXT tries to offer the products that they create at low-cost options. A lot of their products are offered in a disposable way. Their products have helped to raise the success rate of minimally invasive products for many years. Marc Beer is proud to be a part of such an amazing company that is doing great things. After many years of success with LumeNXT Marc Beer decided to start his own business called Renovia Inc. This company is helping to create products for women suffering from pelvic floor disorders. He started this company around the year 2016.
Marc Beer is changing the world one patient at a time. Through his work with both companies, he is helping to create products that are going to be around for a very long time. Marc Beer is already very successful thanks to LumeNXT but having his own company now is really going to take his success on to the next level. There is no stopping him now. Marc Beer is going to see nothing but success for many more years and he is going to take these two companies up the ladder with him. There is no telling just how far he will go. Learn more: https://www.prnewswire.com/news-releases/lumenxt-names-marc-beer-chairman-of-the-board-300822547.html
Marc Beer is an experienced salesman specializing in the medical field. He has played a crucial part in the commercialization of dozens of drugs. He brings to the table over 25 years of experience. His career has been a trail of repeated success stories. He founded Renovia and successfully managed to raise funds with the help of his close friend and colleague Yolanda Lorie. In 2000, Marc Beer was appointed as the acting CEO of ViaCell. ViaCell is a biotechnology company that specializes in the storage and manipulation of umbilical cord blood stem cells for future use. Over a cause of seven years, he has led the company from one triumph to another. The company was able to enlist some of the wealthiest women in its clientele. The company was acquired seven years later after going public with an initial public offer.
While working at ViaCell, Marc Beer was also an active member of the board of directors at Erytech Pharma. Erytech Pharma was at the time a biopharmaceutical company. Prior to founding ViaCell, Marc Beer performed various roles at Genzyme. He was tasked with responsibilities such as the commercial launch of several products that addressed people affected by rare diseases all over the world. During his years working in these different companies, he gained invaluable experience that earned him a spot at LumeN XT as chairperson of the board. Learn more: https://email@example.com
Marc Beer’s new role at LumeN XT
Any medical professional would be fascinated by the innovations that are being advanced by lumeN XT. With Marc Beer as the new chairperson of the board, the company is sure to make better advancements in the surgical field. The company has been working to develop tools that can be used to enable surgeons to see the human body without having to use invasive techniques. Should the technology be advanced, many surgeries can be performed without invasive procedures, making them simpler and improving the healing processes.
In an interview, Marc Beer stated that he was humbled to be picked for the position as well as excited to venture into this new creative and innovative field. He expressed his gratitude for the team of dedicated and hard working professionals that he will be working with. The new approach to surgery could make the treatment of certain diseases less life-threatening in-turn, reducing the mortality rate. The company planned to use heat reduction technologies to increase the accuracy of vision by up to 20%. Precise vision also enhances the efficiency of the surgeon as well as the effectiveness of the surgery as an option for treatment. Marc Beer expressed his motivation to push forward with the research and ensure that the best goals are achieved within the shortest time possible. With his excellent record, Marc Beer is sure to accomplish great things at LumeN XT.
Renovia is an up and coming biotech company that was founded in Boston that specializes in Pharmaceuticals, diagnostics, devices, and biotechnology. Renovia was co-founded by Marc Beer, a man with more than 20 years of experience in the pharmaceutical industry and as an entrepreneur. Marc is constantly on the outlook for new growth at Renovia and he has his heart set on new innovations to facilitate new growth. Tens of millions of dollars have gone into research at Renovia already in the past couple of years and Marc was able to acquire another 42 million to extend operations and do new research from their second funding round. Learn more: https://renoviainc.com/
Thanks to the innovative new treatments and technology that Renovia is coming up with, many more possibilities are being found when it comes to women’s health. It is estimated that there are more than 250 million people around the world facing urinary incontinence and other symptoms related to pelvic floor disorder. This new treatment that has been discovered by Renovia comes in the form of a digital health platform known as Leva. Leva uses sensory technology in order to gather specific information relating to patients and then provides them with ways to treat their own pelvic floor disorder. Although Renovia has only been in the biotech market for three years, the FDA already approved their Leva product, though it is still going through testing and upgrades.
Marc Beer has been committed to the pharmaceutical industry for decades and he is also a well-established entrepreneur. His enthusiastic personality and determination to succeed are what has driven him to make discoveries others have yet to find. Over the course of his career, Marc Beer has made many contributions to the biotech industry with intelligent innovations that have gone on to help thousands of people. In the past, Marc has worked with many other biotech companies focused on pharmaceuticals, including Biotechnology Innovation Organization, Abbot Laboratories, and Genzyme. Renovia is already on the road to success with generous funding and continued growth on all levels in just a few years. Marc has had experience as a leader at his company Good Start Genetics, which has contributed to his success with Renovia. Follow Marc Beer on LinkedIn